US, German Cannabis Producers Can’t Do Business Together, Here’s Why

Bureaucratic hurdles and an unexpectedly high demand for medical cannabis in Germany have created a bottleneck that’s plagued cannabis patients and producers alike. It would seem as though working with the United States could alleviate some of the pressure, but the federal government in Germany has avoided working with the country’s producers for fear of violating the United Nations Single Convention on Narcotic Drugs.

Until Germany can develop a robust cannabis cultivation industry, its patients will continue to receive their medicine sporadically from Canada or the Netherlands. While 18 varieties of cannabis are supposed to be available, patients are lucky to find four strains at their local pharmacy — a significant issue when German doctors are required to prescribe a specific strain for patients. If that strain’s not available, the prescription is worthless.

Once the Israeli government has defined their guidelines for cannabis export, their medical cannabis will find its way into German pharmacies to help alleviate the recent bottlenecks. Israel is expected to develop a cannabis export system in the next couple of years.

Cannabis farmers in the U.S. West…

Continue reading at Marijuana.com

About Marijuana.com

Marijuana.com is the leading cannabis-related message forum and news site for in-depth, comprehensive cannabis strain and product education, marijuana media, growshop information and pricing. Marijuana.com has been in operation since 1995 and is owned and operated by Weedmaps.com, the most widely used medical and recreational marijuana dispensary locator in the industry.

Leave a Reply

Your email address will not be published. Required fields are marked *